March 22, 2022

Geneva Collaborates with Texas-based AREVA Laboratory to Improve Care for Critically Injured in Combat

 

SAN ANTONIO, TexasThe Geneva Foundation (Geneva) and the Autonomous Reanimation and Evacuation Research (AREVA) Laboratory at Brooks City-Base in San Antonio, Texas announces today the formal establishment of a collaborative research program called AREVA to focus on translational research that addresses combat-relevant trauma and novel critical care interventions.

Founded by 2019 Geneva Researcher of the Year and Principal Investigator Andriy Batchinsky, MD in 2019, AREVA is an extramural research program and laboratory committed to reducing mortality in combat casualties in future military conflict by developing autonomous critical care systems and expeditionary and wearable organ- and life-support technology. AREVA conducts nine combat casualty care-relevant research grants at a prolonged field-care intensive care unit for 72 hours. With around-the-clock expeditionary intensive care capabilities to test realistic trauma care scenarios, AREVA performs simulated high-altitude evacuation scenarios during ground and aeromedical manned and unmanned evacuation of the critically ill.

Geneva’s President and CEO Elise Huszar states, “Dr. Batchinsky has been a Geneva researcher since 2014 and has established himself as a leader in military medicine.” She added, “AREVA is a pioneer in groundbreaking treatments for trauma care and lung injuries – it is an honor to support Dr. Batchinsky and accelerate the vital research at the AREVA lab.”

“We are especially interested in studying the most severe casualties that at present are classified as having non-survivable injuries,” said Dr. Batchinsky. “This can only be done by focused study of the similar types of injuries that our warfighters receive.” He added, “AREVA has taken injuries seen in the conflicts in Afghanistan and Iraq and adapted them to the pre-clinical research space.”

AREVA is also investigating early post-injury point-of-care extracorporeal life support. “These technologies provide single or multiorgan support immediately after injury,” says Dr. Batchinsky. “We believe that earlier and wider application of these technologies will directly result in improved patient outcomes.”

Another research priority at AREVA is the development of novel biologically-friendly surfaces and coatings for medical devices which are in direct contact with blood. Led by Principal Investigator Dr. Teryn Roberts, the goal is to develop blood-friendly extracorporeal circulation applications and organ and life support devices.

AREVA has a strong record of successful collaboration with universities, government agencies, clinical care teams, and industry leaders in all phases of research.

“Because of the combination of critical care expertise, technical capabilities mimicking austere care and evacuation, as well as efficiency and expediency in project execution delivered by The Geneva Foundation, I believe AREVA is slated to become the ’go-to’ place for military and civilian trauma research,” says Dr. Batchinsky.

Visit the AREVA webpage to learn more about AREVA’s capabilities, current projects, research collaborations, and to connect with the AREVA team.

 

About The Geneva Foundation

The Geneva Foundation is a 501(c)3 non-profit organization that advances military medicine through innovative scientific research, exceptional program management, and a dedication to U.S. service members and veterans, their families, and the global community. Geneva is proud to have nearly 29 years of experience in delivering full-spectrum scientific, technical, and program management expertise in the areas of federal grants, federal contracts, industry-sponsored clinical trials, and educational services. www.genevaUSA.org

###

MEDIA INFO

To request an interview, contact our Media Relations team.


253-383-1398

Media Info

To request an interview, contact our Media Relations team.


253-383-1398